Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Dr Kimberley Reid
Developmental Neurosciences
Zayed Centre for Research into Rare Disease in Children
20 Guilford Street
Dr Kimberley Reid profile picture
  • Research Fellow
  • Developmental Neurosciences Dept
  • UCL GOS Institute of Child Health
  • Faculty of Pop Health Sciences
Research Summary

My research is focused on understanding the neurobiology of complex childhood genetic disorders. 

In my current role, I use whole genome and exome sequencing to identify novel variants in undiagnosed patients, and analyse them using mammalian overexpression systems and in vitro functional assays. By doing this, we are not only able to understand the genetic aetiology of previously uncharacterised conditions, but work towards elucidating precise therapeutic options for the patients in question.I am currently interested in movement based disorders, in particular those involving the dopaminergic system, as well as diseases involving SLC6 transporters and associated synaptopathies, as well as NMDA receptor signalling.

Previously, I have investigated Epilepsy causing NMDAR using threedifferent strategies. Firstly, neuronal stem cells have been edited usingCRISPR/Cas9 genome editing to generate a human cell model of NMDAR mediatedepilepsy. Secondly, mutant NMDAR constructs (generated by site directedmutagenesis) were overexpressed in HEK293 cells, and receptor functionexplored using biochemical and cell signalling assays (Western blotting,immunocytochemistry, calcium imaging and cell fractionation). Finally, mouselines containing two epilepsy causing NMDA mutations have been generated inorder to assess how the mutation affects NMDAR function in a mammalian model.Therapeutic strategies will be tested on models to streamline options for clinical trials.

I have also previously used a CRISPR/Cas9 DNA editing approach to mutate the Dopamine Transporter (DAT) in zebrafish to model the dopaminergic dysfunction disorder Dopamine Transporter Deficiency Syndrome (DTDS), in order to gain further insight into disease mechanism. 

Teaching Summary

Oct 2014 to Jan 2020 - Lectures delivered on the following courses at UCL SoP – 

PHAY3104 8A  - Physiological Gender Differences And Common Diseases In Women

•Physiological Gender differences

•Common disorders in pregnancy (Hypertension, Diabetes, Depression and Epilepsy) 

•Gynaecological cancers

•Setting and marking of exam questions

PHAYM055/G055 Women's Health

•Poster presentations and marking

PHAYM016/G016 Molecular Basis of Disease

•Genetics and Genetic Disorders 

•Genetic Models of Disease 

PHAYG023 New Drug Targets in the CNS

•Stem cells as a novel CNS Therapeutic 

•NMDA receptor dysfunction 

I have also delivered tutorials and practical classes on a variety of topics including statistics, ocular pharmacology and molecular biology and biochemistry 

Academic Background
2014   Doctor of Philosophy Royal Veterinary College
2010   BSc (Hons) Open Cardiff University
Some IRIS profile information is sourced from HR data as explained in our FAQ. Please report any queries concerning HR data shown on this page to hr-services@ucl.ac.uk.
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by